Lanthanum Carbonate Chewable Tablets — Class II drug recall D-0043-2025
Ongoing recall by Cipla USA, Inc., reported 2024-11-20, distributed nationwide. Failed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets.
| Recall number | D-0043-2025 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Cipla USA, Inc., Warren, NJ, United States |
| Recall initiated | 2024-10-23 |
| Classified | 2024-11-12 |
| Reported by FDA | 2024-11-20 |
| Distributed | Nationwide (US) |
| Quantity | 1,875 boxes |
| NDC | 69097-0936-98 |
| Lot numbers | NB240316 |
| Expiration dates | 2025-12-31 |
Product
Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Cipla USA, NDC 69097-0936-98
Reason for recall
Failed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0043-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.